MB-66

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameMB-66
Drug Alias NameMapp-66MB-66
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionEnvelope glycoprotein gp160 inhibitorsTransmembrane glycoprotein gp41 inhibitors
TargetsEnvelope glycoprotein gp160Transmembrane glycoprotein gp41
Therapy Area/IndicationsHerpes SimplexHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMapp Biopharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKBio Inc
Active IndicationsN/A
Inactive IndicationsHerpes SimplexHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A